Advertisement
Advertisement
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
2.20
USDSponsored
-0.10
-4.35%
Nov 10, 15:59 UTC -5
Closed
After-Market
2.29
+0.09
+3.91%
BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)
BridgeBio Oncology Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 183.28M |
| Beta | 0.86 |
| Earnings Per Share (EPS) | -2.76 |
| Price-to-Book (P/B) Ratio | 0.57 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -46.90% |
| Current Ratio | 4.69% |
| Free Cash Flow | -80.35M |
